> MELVILLE, N.Y.--(BUSINESS WIRE)--Mar. 26, 2020-- Henry Schein, Inc. (Nasdaq: HSIC) announced today the availability of an antibody rapid blood test, known as Standard Q COVID-19 IgM/IgG Rapid Test
...
> The Company anticipates having at least several hundred thousand tests available by March 30 and significantly increased availability beginning in April 2020.
...
> Because serology tests measure antibodies, they can help assess the likelihood of past as well as present infection, and are meant to be used as an aid to health care professionals in diagnosing the mid- to later stages of the viral infection. Along with other information, such as the presence of symptoms, the tests may help health care professionals assess whether individuals (including health care workers) have recovered from the virus.
> MELVILLE, N.Y.--(BUSINESS WIRE)--Mar. 26, 2020-- Henry Schein, Inc. (Nasdaq: HSIC) announced today the availability of an antibody rapid blood test, known as Standard Q COVID-19 IgM/IgG Rapid Test
...
> The Company anticipates having at least several hundred thousand tests available by March 30 and significantly increased availability beginning in April 2020.
...
> Because serology tests measure antibodies, they can help assess the likelihood of past as well as present infection, and are meant to be used as an aid to health care professionals in diagnosing the mid- to later stages of the viral infection. Along with other information, such as the presence of symptoms, the tests may help health care professionals assess whether individuals (including health care workers) have recovered from the virus.
From http://investor.henryschein.com/news-releases/news-release-d...